Evidence map›Paper›PMID 34735901›Full record

ArticleJournal of stroke and cerebrovascular diseases : the official journal of National Stroke Association2022

Shortening Door-to-Needle Time by Multidisciplinary Collaboration and Workflow Optimization During the COVID-19 Pandemic.

Yimin Chen, Thanh N Nguyen, Jack Wellington, Mohammad Mofatteh, Weiping Yao, Zhaohui Hu, Qiuping Kuang, Weijuan Wu, Xuejun Wang, Yu Sun and 4 more

Open access · bronzeAbstract read
In one paragraph

Article in Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed, 2 pooled it
4.1field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 2 syntheses or guidelines pooled it, 32 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Observational
  4. Article
  5. Article
  6. Article
  7. Application of multidisciplinaryWorld journal of emergency medicine · 2024
    Article
  8. The Impact of Pandemic-Driven Care Redesign on Hospital Efficiency.Risk management and healthcare policy · 2024
    Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Observational
  15. Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 6 institutions in 4 countries.

Yimin ChenDepartment of Neurology and Advanced National Stroke Center, Foshan Sanshui District People's Hospital, No. 16, Guanghaidadaoxi, Sanshui District, Foshan, Guangdong Province 528100, China.
Thanh N NguyenThanh N. Nguyen Department of Neurology, Radiology, Boston University School of Medicine, Boston, MA, United States. Electronic address: thanh.nguyen@bmc.org.
Jack WellingtonSchool of Medicine, Cardiff University, Wales, United Kingdom. Electronic address: wellingtonj1@cardiff.ac.uk.
Mohammad MofattehSchool of Medicine, Dentistry and Biomedical Sciences, Queen's University Belfast, United Kingdom. Electronic address: mmofatteh01@qub.ac.uk.
Weiping YaoDean Office, Foshan Sanshui District People's Hospital, Foshan, Guangdong Province, China.
Zhaohui HuMedical Department, Foshan Sanshui District People's Hospital, Foshan, Guangdong Province, China.
Qiuping KuangDepartment of Neurology and Advanced National Stroke Center, Foshan Sanshui District People's Hospital, No. 16, Guanghaidadaoxi, Sanshui District, Foshan, Guangdong Province 528100, China.
Weijuan WuDepartment of Neurology and Advanced National Stroke Center, Foshan Sanshui District People's Hospital, No. 16, Guanghaidadaoxi, Sanshui District, Foshan, Guangdong Province 528100, China.
Xuejun WangDepartment of Neurology and Advanced National Stroke Center, Foshan Sanshui District People's Hospital, No. 16, Guanghaidadaoxi, Sanshui District, Foshan, Guangdong Province 528100, China.
Yu SunDepartment of Neurology and Advanced National Stroke Center, Foshan Sanshui District People's Hospital, No. 16, Guanghaidadaoxi, Sanshui District, Foshan, Guangdong Province 528100, China.
Kexun OuyangDepartment of Radiology, Foshan Sanshui District People's Hospital, Foshan, Guangdong Province, China.
Junmiao XuDepartment of Neurology and Advanced National Stroke Center, Foshan Sanshui District People's Hospital, No. 16, Guanghaidadaoxi, Sanshui District, Foshan, Guangdong Province 528100, China.
Weiquan HuangMedical Intern, Foshan Sanshui District People's Hospital, Foshan, Guangdong Province, China; School of Medicine, Shaoguan University, Shaoguan, Guangdong Province, China.
Shuiquan YangDepartment of Neurology and Advanced National Stroke Center, Foshan Sanshui District People's Hospital, No. 16, Guanghaidadaoxi, Sanshui District, Foshan, Guangdong Province 528100, China. Electronic address: yangshuiquan1969@126.com.
Foshan Second People's Hospital · CNBoston University · USCardiff University · GBFoshan Hospital of TCM · CNQueen's University Belfast · GBShaoguan University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectivesThis study aims to evaluate shortening door-to-needle time of intravenous recombinant tissue plasminogen activator of acute ischemic stroke patients by multidisciplinary collaboration and workflow optimization based on our hospital resources. MATERIALS AND

methodsWe included patients undergoing thrombolysis with intravenous recombinant tissue plasminogen activator from January 1, 2018, to September 30, 2020. Patients were divided into pre- (January 1, 2018, to December 31, 2019) and post-intervention groups (January 1, 2020, to September 31, 2020). We conducted multi-department collaboration and process optimization by implementing 16 different measures in prehospital, in-hospital, and post-acute feedback stages for acute ischemic stroke patients treated with intravenous thrombolysis. A comparison of outcomes between both groups was analyzed.

resultsTwo hundred and sixty-three patients received intravenous recombinant tissue plasminogen activator in our hospital during the study period, with 128 and 135 patients receiving treatment in the pre-intervention and post-intervention groups, respectively. The median (interquartile range) door-to-needle time decreased significantly from 57.0 (45.3-77.8) min to 37.0 (29.0-49.0) min. Door-to-needle time was shortened to 32 min in the post-intervention period in the 3rd quarter of 2020. The door-to-needle times at the metrics of ≤ 30 min, ≤ 45 min, ≤ 60 min improved considerably, and the DNT> 60 min metric exhibited a significant reduction.

conclusionsA multidisciplinary collaboration and continuous process optimization can result in overall shortened door-to-needle despite the challenges incurred by the COVID-19 pandemic.

Indexed as

Cooperative BehaviorPatient Care TeamAdministration, IntravenousBrain IschemiaCOVID-19Early Medical InterventionEmergency Medical ServicesFemaleFibrinolytic AgentsHumansIschemic StrokeMalePandemicsSARS-CoV-2Thrombolytic TherapyTime ManagementFibrinolytic AgentsTissue Plasminogen ActivatorAcute ischemic strokeCOVID-19 pandemicDoor-to-Needle TimeThrombolysis

Identifiers

PMID34735901
PMCPMC8526426
OpenAlexW3206401178

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.